About: SARS‐CoV‐2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: SARS‐CoV‐2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	SARS‐CoV‐2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens
Creator	Liu, Jing Peng, Liang Li, Xuejun Gao, Zhiliang Lin, Bingliang Chen, Dabiao Huang, Zhanlian Lei, Ziying Xu, Wenxiong Deng, Keji Luo, Qiumin
source	Medline; PMC
abstract	PURPOSE: The purpose of this study was to detect severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) ribonucleic acid (RNA) in urine and blood specimens, and anal and oropharyngeal swabs from patients with confirmed SARS‐CoV‐2 infection, and correlated positive results with clinical findings. METHODS: Patients with confirmed SARS‐CoV‐2 infections were included in this study. Patients' demographic and clinical data were recorded. Quantitative real‐time polymerase chain reaction was used to detect SARS‐CoV‐2 RNA in urine and blood specimens, and anal and oropharyngeal swabs. The study is registered at http://ClinicalTrials.gov (No. NCT04279782, 19 February, 2020). RESULTS: SARS‐CoV‐2 RNA was present in all four specimen types, though not all specimen types were positive simultaneously. The presence of viral RNA was not necessarily predictive of clinical symptoms, for example, the presence of viral RNA in the urine did not necessarily predict urinary tract symptoms. CONCLUSIONS: SARS‐CoV‐2 can infect multiple systems, including the urinary tract. Testing different specimen types may be useful for monitoring disease changes and progression, and for establishing a prognosis.
has issue date	2020-04-30(xsd:dateTime)
bibo:doi	10.1002/jmv.25936
bibo:pmid	32330305
has license	no-cc
sha1sum (hex)	005d2dab672c2c970d0346dd9015363ddad3fd05
schema:url	https://doi.org/10.1002/jmv.25936
resource representing a document's title	SARS‐CoV‐2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens
has PubMed Central identifier	PMC7264521
has PubMed identifier	32330305
schema:publication	J Med Virol
resource representing a document's body	covid:005d2dab672c2c970d0346dd9015363ddad3fd05#body_text
is schema:about of	named entity 'SARS-CoV-2' named entity 'urinary tract' named entity 'urine' named entity 'polymerase' covid:arg/005d2dab672c2c970d0346dd9015363ddad3fd05 named entity 'Patients' named entity 'SARS-CoV-2' named entity 'Quantitative' named entity 'urine' named entity 'viral' named entity 'positive' named entity 'SARS-CoV-2' named entity 'real-time polymerase chain reaction' named entity 'SARS-CoV-2' named entity 'infection' named entity 'ClinicalTrials.gov' named entity 'urine' named entity 'urine' named entity 'supplemental oxygen' named entity 'hematological' named entity 'inhalation' named entity 'CDC' named entity 'infection' named entity 'Fatigue' named entity 'interferon alfa' named entity 'organ systems' named entity 'Sore throat' named entity 'antiviral treatment' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'Sputum' named entity 'lopinavir/ritonavir' named entity 'SARS-CoV-2' named entity 'isolation unit' named entity 'Cough' named entity 'Diarrhea' named entity 'Urinary tract' named entity 'Dyspnea' named entity 'Sneezing' named entity 'arbidol' named entity 'nucleic acid detection' named entity 'clinical data' named entity 'SARS-CoV-2' named entity 'urine' named entity 'viral RNA' named entity 'SARS-CoV-2' named entity 'oropharyngeal' named entity 'RNA' named entity 'chain reaction' named entity 'acid' named entity 'patients' named entity 'RNA' named entity 'urinary tract' named entity 'SARS-CoV-2' named entity 'clinical symptoms' named entity 'SARS-CoV-2' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'RNA' named entity 'oropharyngeal' named entity '19 February' named entity 'urine' named entity 'RNA' named entity 'oropharyngeal' named entity 'viral RNA' named entity 'clinical findings' named entity 'ribonucleic acid' named entity 'demographic' named entity 'SARS-CoV-2' named entity 'positive' named entity 'oropharyngeal' named entity 'Purpose'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software